Recommended Conferences

  • 2nd International Conference on 3D Printing Technology and Innovations March 19-20, 2018 London, UK
    March 19-20, 2018 London, UK
  • 7th World Congress on Immunology April 19-20, 2018 Amsterdam, Netherlands
    April,2018 Amsterdam, Netherlands
  • 4th World Congress and Exhibition on Antibiotics and Antibiotic Resistance June 14-15, 2018 Barcelona, Spain
    June ,2018 Barcelona, Spain
  • 10th International Conference on Clinical and Cellular Immunology August 6-7, 2018 Madrid, Spain
    August,2018 Madrid, Spain
  • 11th Annual Congress on Immunology & Immunotechnology September 13-14, 2018 Zurich, Switzerland
    September, 2018 Zurich, Switzerland
  • 12th International Conference on Allergy, Asthma & Clinical Immunology 01-02 Oct 2018 ,Moscow, Russia
    Oct 2018 ,Moscow, Russia

Di YU

Di YU
Post Doctrate,Department of Immunology,Genetics and Pathology Uppsala University,Sweden.
 
Biography
Di Yu is born in Hangzhou, Zhejiang province in P. R. of China. He started his research in Prof. Xiaochen Li?s lab in Shaanxi Normal University where he investigated the Tardigrade fauna in China and has discovered 6 new species of Tardigrade. After that, he started working at Prof. Essand lab in Uppsala University in Sweden and got his PhD degree in 2013. During that time, he developed a new technology for adenovirus surface modification and has developed a novel oncolytic adenovirus for treatment of neuroendocrine cancer. This work was further supported by public donation and a clinical trial was started in 2016 to evaluate this virus on patients suffering neuroendocrine cancer. During his postdoc training, he developed a new technology for long-term T-cell engineering without the genome insertion of transgene. This work decreases the genotoxicity of the currently used viral vectors in cell engineering. He is now in the phase of establishing his own group and the research is focused on virus-mediated immunotherapy for cancer.
 
Research Interest
Viral vectors,Oncolytic virus,Virus induced celldeath, Immunotherapy,CAR-T cells,Immunogenic cell death
 

Relevant Conferences